BPC-157 + TB-500 Blend 10mg
A pre-blended combination of BPC-157 and TB-500 in a single vial. BPC-157 operates through nitric oxide system modulation and VEGF upregulation, while TB-500 works through G-actin sequestration promoting cell migration. Research on both peptides individually supports complementary tissue repair mechanisms.
Sequence
Blend: BPC-157 (5mg) + TB-500 (5mg) per vial
Market avg: $79.99 — save 44%
Volume pricing
Pay with USDC via Coinbase Commerce
Certificate of Analysis
Independently verified by Janoshik Analytical
Test ID
JAN-BPCTB-2026-001
Purity
98.8%
Method
HPLC-MS
Batch
BPCTB-2026-01A
Test Date
February 1, 2026
Identity
Confirmed
Endotoxin
<0.5 EU/mg
Sterility
Pass
Storage Requirements
Lyophilized
Room temperature (15-25°C), protect from light
Reconstituted
2-8°C, use within 21 days
Pre-blended recovery peptides. Reconstitute with bacteriostatic water.
Published Research
2 peer-reviewed studies
Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract
Sikiric P, Seiwerth S, Rucman R, et al. — Current Pharmaceutical Design, 2011
Comprehensive review of BPC-157 cytoprotective mechanisms.
Thymosin β4 is an endogenous iron chelator and molecular switchblade molecule
Goldstein AL, Hannappel E, Sosne G, Kleinman HK. — Annals of the New York Academy of Sciences, 2012
Review of thymosin beta-4 biology including regenerative properties.
Related Products
Research use only. All products are sold strictly for in-vitro research purposes only. Not for human consumption. Information provided references published research literature. No medical claims are made or implied.